Toll Free Helpline (India): 1800 1234 070

Rest of World: +91-9810852116

NAAS RATING: 5.23, Impact Factor: RJIF 5.98 | Free Publication Certificate
NAAS Rating: 5.23 new

Vol. 2, Issue 5 (2013)

The Ways of Optimizing Treatment the Patients with Liver Cirrhosis

Iryna Gavrysh
We examined 65 patients with liver cirrhosis combined with intestinal dysbiosis, studied the influence of the characteristics of its flow intestinal microbiota and included in the combined treatment of medications of Lactobacillus and Bifidobacterium – «Bifilakt Extra» (LB) and Methylsiliconic acid hydrogel – «Enterosgelum » (MAH)Inclusion to the complex treatment of the patients suffering from cirrhosis of medications LB and MAH led to a significantly better reduction of subjective and objective symptoms of liver cirrhosis, regimentation indicators of intestinal microbiota and symptoms of hepatic encephalopathy.
Pages: 86-90  |  1283 Views  9 Downloads

The Pharma Innovation Journal
How to cite this article:
Iryna Gavrysh. The Ways of Optimizing Treatment the Patients with Liver Cirrhosis. Pharma Innovation 2013;2(5):86-90.
Important Publications Links
The Pharma Innovation Journal

The Pharma Innovation Journal

Call for book chapter
The Pharma Innovation Journal